Atlas Trials

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

Clinical trial NCT02616497 · COMPLETED

Trial details

NCT number
NCT02616497
Sponsor
University of Ioannina
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atherothrombosis
Start date
2015-09-01
Primary completion
2017-02-28
Enrollment
1220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.